The Gem's Edge: George Cumberland, Glyptic Art, and Eighteenth‐Century Outline
Journal for Eighteenth-Century Studies · 06.08.2026
DOI: 10.1111/1754-0208.70052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for Eighteenth-Century Studies, online erschienen am 06.08.2026. Verfasst von Ollie Croker.
Abstract (Originalsprache)
This article repositions glyptic art — engraved gems, cameos, and their impressions — as a significant but overlooked influence on British Neoclassical outline. Rather than treating Greek vase painting as the sole model for the outline style of engraving associated with artists like John Flaxman, it argues that outline arose from a broader range of Classical sources. Central to this reassessment is George Cumberland (1754–1848), whose Thoughts on Outline (1796) and Outlines from the Antients (1829) propose a softened, blended contour derived from close study of gems, as well as an appreciation of smaller antiquities, including bronzes and terracotta reliefs. Reconstructing Cumberland's dispersed gem cabinet through William Tassie's impressions and objects in the British Museum shows how the material qualities of intaglios and cameos shaped his critique of engraving and influenced later versions of Flaxman's Homeric plates. Recentring gems within Neoclassical visual culture challenges assumptions about outline's origins and broadens our understanding of Classical influence in late eighteenth‐century Britain.
Zitieren
APA
Croker, O. (2026). The Gem's Edge: George Cumberland, Glyptic Art, and Eighteenth‐Century Outline. Journal for Eighteenth-Century Studies. https://doi.org/10.1111/1754-0208.70052
Vancouver
Croker O. The Gem's Edge: George Cumberland, Glyptic Art, and Eighteenth‐Century Outline. Journal for Eighteenth-Century Studies. 2026. doi:10.1111/1754-0208.70052
BibTeX
@article{Croker2026,
author = {Croker, Ollie},
title = {The Gem's Edge: George Cumberland, Glyptic Art, and Eighteenth‐Century Outline},
journal = {Journal for Eighteenth-Century Studies},
year = {2026},
doi = {10.1111/1754-0208.70052}
}
EUVIMED